Drugs / LEO 134310
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03669757 | Sep 2018 → Feb 2019 | psoriasis | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEO 134310 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03669757 ↗ |
| Route | Topical | “LEO 134310 cutaneous solution” NCT03669757 ↗ |